Akebia Therapeutics
Clinical trials sponsored by Akebia Therapeutics, explained in plain language.
-
Oral hope for young kidney Patients' anemia withdrawn before start
Disease control TerminatedThis study aimed to test a daily oral pill called vadadustat for treating anemia in children with chronic kidney disease. It planned to see if the pill was safe and effective for kids switching from standard injectable anemia treatments. The trial was withdrawn before any partici…
Phase: PHASE3 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Daily pill tested to boost blood health in kids with kidney problems
Disease control TerminatedThis study aimed to test the safety and effectiveness of a once-daily pill called vadadustat for treating anemia (low red blood cells) in children with chronic kidney disease. It was designed for kids who had not yet received standard injectable anemia treatments. The trial was w…
Phase: PHASE3 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New pill challenges standard injection for dialysis Patients' anemia
Disease control OngoingThis study is testing if a pill called vadadustat, taken three times a week, works as well as the standard injected medication (ESA) for treating anemia in adults on kidney dialysis. It aims to see if the pill can safely raise and maintain healthy red blood cell levels, potential…
Phase: PHASE3 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated Mar 03, 2026 14:06 UTC